[Immunohistology in breast diagnostics : Strategies for efficient diagnostics]

Christina C Westhoff1, Annette Ramaswamy2, Matthias Kalder3

  • 1Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Gießen und Marburg (UKGM), Baldingerstr., 35043, Marburg, Deutschland. westhoff@med.uni-marburg.de.

Summary

Immunohistology aids breast cancer diagnosis by differentiating malignant from benign cells. Key markers like ER, PR, HER2, Ki-67, and PD-L1 are crucial for accurate histopathological assessment and treatment decisions.